Shamrock Group

Shamrock Pharma Group positions itself as the right API partner in India, for APIs, intermediates and carbapenems, having acquired ownership of 4 manufacturing facilities, 3 R&D labs and one pilot plant dedicated to CRAMS manufacturing and APIs/intermediates. The group recently acquired Unimark Remedies and carbapenem facilities spanning from basic stage to sterile injectable vials, and is seeking marketing network partners for exclusive marketing of its APIs.